UK's Judges Scientific H1 revenue, profit fall amid offshore wind weakness

By Reuters News


Overview

  • UK scientific instruments group's H1 revenue fell 21% amid challenging end markets

  • Adjusted pre-tax profit dropped 75% as cost cuts only partly offset lower volumes

  • Company maintained full-year earnings guidance and raised interim dividend by 10%


Outlook

  • Judges Scientific maintains 2026 guidance for adjusted EPS in line with market expectations of 200.5p

  • Company expects no Geotek coring expedition revenue in 2027; consensus adjusted EPS seen at 224.9p

  • Company says US research funding environment remains challenging; signs of improvement in China procurement


Result Drivers

  • MARKET HEADWINDS - Reduced US research funding, delays in China procurement, and offshore wind weakness weighed on H1 performance

  • BUSINESS GROWTH IN SELECT SECTORS - Eight businesses grew, supported by operational initiatives and healthier conditions in semiconductors and battery development


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

H1 Revenue

GBP 55.7 mln

H1 Adjusted Pretax Profit

GBP 3.2 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy."

  • Wall Street's median 12-month price target for Judges Scientific PLC is GBp6,500.00, about 71.5% above its September 22 closing price of GBp3,790.00

  • The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 21 three months ago


Reuters Recommended Reads

  • Sept 22 - UK's Smiths Group FY revenue beats estimates, margin expands


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.